Takeda has announced the appointment of Julie Kim as successor to Christophe Weber, its current president, CEO and representative director, effective from June 2026. The decision was unanimously ...

When Julie Kim ’97 MBA graduated from the Kellogg School of Management ... You can sense this in other Kellogg graduates when you meet them out in the world.” President of Takeda Pharmaceutical ...

Takeda boosts profit margins with AI-driven growth, FY2024 guidance upgrade, share buyback plan & promising drug launches.

Weber – who was briefly chief operating officer of Takeda before rising to the CEO role and was the first non-Japanese person to lead the 243-year-old company – will be replaced by Julie Kim ...